Trials / Completed
CompletedNCT03291041
A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Vanda Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tasimelteon | capsule |
| DRUG | Placebo | capsule |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2017-11-01
- Completion
- 2017-11-01
- First posted
- 2017-09-25
- Last updated
- 2021-11-03
- Results posted
- 2021-11-03
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03291041. Inclusion in this directory is not an endorsement.